SciSparc (SPRC) Seeks to Identify Potential Strategic Transaction Opportunities

[ad_1] SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system,…